DataBreachSearch.com
All cases
investigating

Amedisys Confirms Data Breach Reported to Texas Attorney General

Amedisys, a healthcare service provider, officially reported a data security incident to the Texas Attorney General on April 2, 2026. This incident involved unauthorized access to their systems, meaning personal information may have been compromised for those who received notification letters.

Compiled from official Attorney General recordsLast updated
State
Texas
Breach date
October 31, 2025
Reported
April 2, 2026

Amedisys, a prominent provider of home health, hospice, and high-acuity care services, has confirmed a data security incident. The company filed an official report with the Texas Attorney General's office on April 2, 2026, detailing unauthorized access to its systems. This public filing serves to inform individuals potentially affected by the breach.

According to the filing, the security incident occurred on or around October 31, 2025. The company's investigation into the unauthorized access is ongoing. This means Amedisys is actively working to understand the full scope and impact of the event.

While the specific categories of data involved were not detailed in the public record, individuals who received a notification letter from Amedisys should understand that their personal information may have been accessed. The notification letter is intended to provide specific details relevant to the recipient's situation.

If you received such a letter, it is recommended to remain vigilant for any unusual activity related to your accounts and personal information. Consider monitoring financial statements and credit reports for suspicious transactions or inquiries. You may also want to change passwords for online accounts and be cautious of unsolicited communications that request personal details.

This information is based on public disclosures made by Amedisys to the Texas Attorney General. For the most accurate and personalized details regarding your situation, please refer to any official correspondence you have received directly from Amedisys.